New opportunity - this is a non clinical PhD 4 year program - have a look and DM me if wish to discuss this particular student ship in modelling high risk Leukemia.
If that doesn’t take your fancy - there are plenty of exciting projects here!
17.10.2025 13:11 — 👍 2 🔁 2 💬 0 📌 0
Wow am I 😎 as well?! Thanks Alba!
07.10.2025 16:07 — 👍 0 🔁 0 💬 1 📌 0
Interested in PhD in CRISPR engineering to develop new models of myeloid malignancies?!
Join me @cruk-mi.bsky.social
www.crukcentre.manchester.ac.uk/opportunitie...
For Clinically trained applicants-DM if you have queries
Deadline 17th November 2025
07.10.2025 15:46 — 👍 5 🔁 3 💬 0 📌 1
Very excited to join Manchester in the coming months and to continue work from the DFCI! Thanks to the great team here and from Ben for his mentorship and support.
28.08.2025 22:08 — 👍 8 🔁 1 💬 0 📌 0
Congrats!
02.07.2025 15:20 — 👍 0 🔁 0 💬 0 📌 0
Learn which oral abstracts the Scientific Program co-chairs thought were Best of #ASH24! Stream the Best of ASH session on the virtual meeting platform. 💻
#ASHKudos Drs. Jennifer Trowbridge (@trowbridgelab.bsky.social) & Sant-Rayn Pasricha for a superb job!
#HemeSky #Bloodsky #Hematology
21.12.2024 16:01 — 👍 11 🔁 2 💬 0 📌 0
Physician-scientist studying spatial organization of bone marrow in marrow failure and myeloid malignancies. Views my own.
Biochemist of histone and chromatin biology. Group Leader. University of Liverpool.
A cross-border hub to develop & validate #AI techniques for anonymization & synthetic data generation in rare hematological diseases 🔬🩸🇪🇺 #HorizonEU project
👉 https://synthema.eu/
Research Integrity and Training Adviser at the Cancer Research UK Manchester Institute
Interested in improving #ResearchIntegrity & #ResearchCulture with training, #TeamScience & promoting #OpenResearch
https://orcid.org/0000-0002-3353-7002
Portfolio of peer-reviewed journals from ASH including Blood, the most cited peer-reviewed publication in hematology, and Blood Advances, Blood Global Hematology, Blood ICT, Blood Neoplasia, Blood RCI, and Blood VTH https://linktr.ee/bloodjournalsportfolio
This account is not actively posting follow us @bloodjournals.hematology.org for the latest from Blood Journals Portfolio.
Senior Lecturer & Consultant Medical Oncologist in Advanced #Immunotherapy + #CellTherapy at The University of Manchester & The Christie • MANIFEST Deputy Lead • ESMO #TranslationalResearch Faculty Lead
🔗 Bio: bit.ly/Christie_JonLim
(tennis enthusiast 🎾)
Cancer cell biologist | Somatic evolution and cancer initiation | postdoc @SwantonLab @TheCrick. Views my own
Regional Vice President Sales and Support EMEA at Vizgen
We are a leading Cancer Research Institute within The University of Manchester, funded by Cancer Research UK (@cancerresearchuk.org)
https://www.cruk.manchester.ac.uk/
Clinician Scientist and Consultant Haematologist | Researches stem cell biology, epigenetics and drug discovery, specialising in B-ALL | Fellow St Catharine's College, Cambridge
Professor of Haematology at University College London Cancer Institute and Great Ormond Street Institute of Child Health. Clinician scientist investigating, caring for and developing new therapies for patients with acute leukaemia
We are a cancer epigenetics lab at the Dana-Farber Cancer Institute, Broad Institute and Harvard Medical School.
Our interests include blood cancer development, chromatin biology, splicing and inflammation.
Physician Scientist at DKFZ & NCT Heidelberg
studying 🩸🧬 #epigenomics #DNAmethylation #singleCell #precisiononcology #JMML
www.translational-cancer-epigenomics.de
Group Leader at the University of Birmingham, UK. Stem cells and genome stability lab. Hematopoiesis, AML, MDS, breast cancer.
Postdoc in Ebert lab, DFCI
Former PhD in Milsom lab, HI-STEM&DKFZ
Haematology doctor & researcher, UK. Interested in blood ageing, transplant, cancer and development. Lapsed musician.
Research fellow @crick.ac.uk #BonemarrowStemCells🩸
#MDS #Cancer
#DiseaseModelling #EnvironmentalMinglingMatters #CureForMDS
ASH-EHA TRTH2025
Opinions are my own!
https://scholar.google.com/citations?user=96tYyXUAAAAJ&hl=en
